ZestyAI launches AI agent for insurers
0
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author.
Regulatory research remains one of the costliest inefficiencies in insurance, with an estimated $2.5 billion spent annually on manual reviews. The process consumes millions of hours across fragmented workflows, as filings often stretch into the thousands of pages, slowing competitive analysis and strategic decision-making.
To solve this, ZestyAI built ZORRO Discover on a proprietary generative AI pipeline, leveraging large language models optimized for insurance-specific content, including filings, objections, responses, and regulations from all 50 states. Using agentic AI, the platform proactively navigates and synthesizes regulatory data, delivering a fast, intuitive experience tailored to the structure and language of insurance filings.
Early adopters of ZORRO Discover have found insurers can cut research time by an average of 95%, saving thousands of work hours and millions in costs.
'For too long, regulatory filings have buried critical intelligence under layers of complexity,' said Kumar Dhuvur, Founder and Chief Product Officer of ZestyAI. 'Through years of working closely with regulators, we've come to deeply understand these challenges. ZORRO Discover puts that intelligence at insurers' fingertips so they can act faster, stay compliant, and make smarter decisions in an increasingly competitive market.'
ZORRO Discover supports compliance, actuarial, product, and strategy teams in accelerating competitive research and reducing regulatory risk. By replacing manual reviews with a consistent, repeatable process, the platform helps teams improve research accuracy, focus on high-impact work, and stay ahead of regulatory changes.
Key capabilities include:
Plain-language search: Analyze and compare filings across carriers, states, and time periods using intuitive queries—no deep regulatory or technical expertise required.
Zero in on critical details instantly: Transform complex filings into executive-level insights for faster, more informed decision-making.
Spot market opportunities early: Track shifts in rates, rules, forms, and guidelines to anticipate industry trends and act proactively.
Run side-by-side comparisons: Evaluate pricing strategies, regulatory objections, or model usage over time and across competitors (e.g., compare windstorm mitigation discounts among major carriers in Florida).
ZORRO Discover launches with a focus on homeowners insurance and is rapidly expanding to support regulatory and competitive intelligence across auto, commercial, and additional lines of business.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
23 minutes ago
- Reuters
Trading Day: Bond blues mar stocks' joy
ORLANDO, Florida, July 15 (Reuters) - TRADING DAY Making sense of the forces driving global markets By Jamie McGeever, Markets Columnist The S&P 500 and Nasdaq leaped to new highs on Tuesday thanks to a surge in Nvidia shares, but closed mixed as investors digested a pick-up in U.S. inflation, a raft of major U.S. financial firms' earnings and spiking bond yields around the world, especially in Japan. More on that below, but in my column today I ask whether there is a sense of tariff complacency creeping into markets, as investors increasingly bet on the 'TACO' trade. If you have more time to read, here are a few articles I recommend to help you make sense of what happened in markets today. Today's Key Market Moves Bond blues mar stocks' joy It was a mixed bag on world markets on Tuesday. Two of Wall Street's three main indices, Britain's FTSE 100 and the MSCI World index hit fresh peaks, yet U.S. inflation rose, bond yields marched higher and investors gave a thumbs down to seemingly solid earnings from U.S. financial firms. Equity market strength was mostly in tech, after AI darling and chipmaker Nvidia said overnight it plans to resume sales of its H20 AI chips to China. Hong Kong's tech index got the ball rolling with a 2.8% rise, and tech was the only sector on the S&P 500 to close in the green. But if the market's glass was half full at the start of the day, it was half empty by the end of it. U.S. inflation was broadly in line with expectations, yet investors focused on the upside risks; U.S. bank earnings were solid, but financials were among the biggest decliners. The shadow of higher bond yields is beginning to lengthen as worries over governments' fiscal health, tariff-driven inflation and investor appetite for fixed income assets pick up again. The 30-year U.S. Treasury yield is back above 5.00%, but the eye of the bond market hurricane appears to be in Japan. Investor angst around an Upper House election on Sunday is bubbling up. Prime Minister Shigeru Ishiba's sliding popularity suggests even his modest goal of retaining a majority is out of reach, and defeat could bring anything from a shift in the makeup of Ishiba's coalition to his resignation. Japanese government bond yields are surging, but that's proving to be a headwind for the yen rather than a tailwind as extra pressure on the country's already strained public finances, a straight-jacketed Bank of Japan and stagflation fears more than offset any potential carry for yen investors. The yen slumped to a three-month low on Tuesday, back within sight of the 150 per dollar mark. The raft of economic indicators from China overnight, meanwhile, generally showed activity in June held up better than economists expected, and second quarter GDP growth was slightly stronger than forecasts too. But Beijing is still under pressure to inject more stimulus into the economy. The property bubble continues to deflate, with new home prices falling at their fastest pace in eight months, and more broadly, China's economic surprises index is its lowest in three months. If incoming data is beating forecasts, it is because expectations have been lowered so much. Tariff 'doom loop' hangs over global equities The astonishing rebound in stocks since early April largely reflects investors' bet that U.S. President Donald Trump won't follow through on his tariff threats. But the market's very resilience may encourage the president to push forward, which could be bad news for equities in both the U.S. and Europe. Investors appear to believe that the April 2 "reciprocal" tariffs were mostly a tactic to bring countries to the negotiating table, and Washington's levies will end up being much lower than advertised. Tariffs may end up much higher than they were before Trump's second term began, but the situation will still be better than the worst-case scenarios initially priced in after Trump's so-called "Liberation Day". Monday's equity moves were a case in point. Trump's threat on Saturday to impose 30% levies on imports from the European Union and Mexico - two of America's largest trading partners - was met with a collective market shrug. European and Mexican stocks dipped a bit, but Wall Street closed in the green and the Nasdaq hit a new high. This follows threats in recent days to place a 50% tariff rate on goods imported from Brazil and a 35% levy on goods from Canada not covered under the USMCA agreement. Brazilian stocks have slipped 5%, but Canadian stocks have hit new peaks. The question now is whether the line between complacency and the "TACO" trade - the bet that "Trump always chickens out" - is getting blurred. The scale of the recovery since April 7 is truly eye-popping. It took the S&P 500 less than three months to move from the April bear market lows to a new all-time high, as Charlie Bilello, chief market strategist at Creative Planning, recently noted on X. This was the second-fastest recovery in the last 75 years, only bested by the bear market recovery in 1982 that took less than two months. On a 12-month forward earnings basis, the S&P 500 index is now near its highest level in years and well above its long-term average. The tech sector, which has propelled the rally, has rarely been more expensive in the last quarter century either. None of that means further gains cannot materialize, and one could argue that the valuations are justified if AI truly delivers the promised world-changing productivity gains. Regardless, it is hard to argue that the rally since April is not rooted in the belief that tariffs will be significantly lower than the levels announced on Liberation Day. If many countries' levies do end up around 10% like Britain's and the aggregate rate settles around 15%, then equity pricing might very well be reasonable. But if that's not the case, growth forecasts will likely have to be revised a lot lower. "We stay overweight U.S. stocks, but don't rule out more sharp near-term market moves. Uncertainty on who will bear tariff costs means yet more dispersion in returns – and more opportunity to earn alpha, or above-benchmark returns," BlackRock Investment Institute analysts wrote on Monday. One concern is that a loop is potentially being created, whereby Wall Street's resilience and strength in the face of heightened trade uncertainty actually emboldens Trump to double down on tariffs. Most analysts still believe cooler heads will prevail, however. Trump's tolerance for equity and bond market stress, and therefore U.S. economic pain, appears "limited", according to Barclays. But if markets have gotten too complacent and Trump does increase tariffs on EU goods to 30%, potential retaliation would risk a repeat of something similar to the post-Liberation Day selloff, sending European equities down by double digits, Barclays warns. It may also be that when it comes to tariffs, investors are focusing so intently on China that not much else moves the dial. This may be short-sighted though. China accounted for 13.4% of U.S. goods imports last year, the lowest in 20 years. In contrast, the U.S. imported $605.7 billion of goods from the European Union, or 18.6% of all imports and the most from any single jurisdiction. As Trump sees it, Europe is "ripping off" America almost as much as China. Bilateral U.S.-China trade last year totaled $582 billion, compared with bilateral U.S.-EU trade flows of $975 billion, U.S. Census data shows. America's $235.9 billion goods deficit with the EU was smaller than its $295.5 billion gaps with China, but that's still comfortably America's second-biggest trade deficit. What could move markets tomorrow? Want to receive Trading Day in your inbox every weekday morning? Sign up for my newsletter here. Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, opens new tab, is committed to integrity, independence, and freedom from bias.
Reuters
23 minutes ago
- Reuters
As class action trial looms, Meta and Flo could face 'mind-boggling' damages
July 15 (Reuters) - It's hard to imagine more intimate queries than those that fertility tracking app Flo allegedly asked its users. Among them: When was your last period? How often do you have sex? Masturbate? Do you get yeast infections? As app maker Flo Health and co-defendant Meta are set to face a class action trial in San Francisco federal court next week for allegedly violating the privacy of millions of Flo users, the question now is whether the companies will cut a deal or risk what Flo on appeal, opens new tab termed "mind-boggling" damages. Litigators sometimes bandy about the phrase 'bet-the-company case,' but this could be the real thing. Facebook parent Meta is defending against claims of violating the California Invasion of Privacy Act, which carries statutory penalties of $5,000 per violation. That would add up to at least $190 billion in damages if, as plaintiffs have previously suggested, opens new tab, there are 38 million class members. If each app entry is treated as a separate violation, total damages could be quadrillions of dollars — "a sum so large it may as well be infinite," as Flo put it. A spokesperson for Meta, which is represented by outside counsel from Latham & Watkins and Gibson, Dunn & Crutcher, said the plaintiffs' claims against the company "are simply false, and we are confident that the evidence at trial will demonstrate the realities." Flo, represented by Dechert, separately is dealing with claims including violations of California's Confidentiality of Medical Information Act, which carries penalties of $1,000 per violation. A spokesperson for the London-based, privately held company said Flo "is committed to protecting the privacy of its users, and any allegation otherwise has no merit." The companies have argued that Flo's privacy disclosures gave users notice of the alleged misconduct and that they impliedly consented, that the shared data did not contain personally identifying information and that Meta never 'intended' to intercept communications. According to the Meta spokesperson, the company does 'not want health or other sensitive information' and its terms 'prohibit developers from sending any.' Google, which was also named in the suit, reached a settlement in principle last week on as-yet undisclosed terms. A Google spokesperson did not respond to my request for comment. Given the risk of outsized verdicts (even those that don't involve 16 figures), class actions rarely go to trial. For example, Google last month took a chance on one involving cellular phone data, only to be hit with a $314 million verdict by a California jury on July 1. The Flo plaintiffs invoke California's 1967 invasion of privacy law, a Cold War relic that makes it illegal to covertly eavesdrop or record telephone conversations. As I previously wrote, the cause of action has enjoyed a resurgence of late among plaintiffs' lawyers, especially in connection with the use of chatbots, tracking pixels and other data analytics software. The Flo jury trial, set for July 21 before U.S. District Judge James Donato, looms as current and former Meta leaders face an $8 billion shareholder suit in Delaware that kicks off Wednesday. The shareholders allege Meta executives violated a 2012 agreement between Facebook and the Federal Trade Commission to protect users' data, my Reuters colleague Tom Hals reports. The Flo class action also has its roots in an FTC case. The agency sued Flo, opens new tab after The Wall Street Journal in 2019 reported that it was able to intercept identifying health information about Flo users transmitted by the app to Facebook. The FTC's 2021 settlement required Flo to obtain users' consent before sharing their health information and to notify affected women about the disclosure. According to the follow-on class action, opens new tab, which covers all Flo app users nationwide from Nov. 1, 2016, to Feb. 28, 2019, plus a California subclass, Flo integrated code from Meta and Google's software development kits, which are used for data analytics, into its app. That allegedly allowed the companies to review personal information on users' menstrual cycles, sex lives and pregnancies, despite promises by Flo that the data would remain confidential. The third parties were "were free to use this data for their own purposes," including marketing and advertising, the complaint alleges. "If Plaintiff and Class members had known that Flo Health would share their intimate health data, they would not have used the Flo App." Plaintiffs' lawyers from Labaton Keller Sucharow; Lowey Dannenberg and Spector Roseman & Kodroff did not respond to requests for comment. Donato certified the class in May, writing, opens new tab that the 'loss of control over one's personal information' is a concrete harm, "whether from stealing access to a personal diary in 1916 or obtaining user information in a healthcare app in 2016.' The decision prompted an interlocutory appeal, opens new tab in June by Flo to the 9th U.S. Circuit Court of Appeals. Flo argued that Donato wrongly held that the company's class action waiver was unenforceable. The judge deemed the provision unconscionable because it was buried in Flo's terms of service. Flo also argued that the company's use of the software development kits is 'a practice as unremarkable as it is widespread,' and that it disclosed using the kits in its privacy policy and terms of service. Flo also said the transmitted data was de-identified, consisting of alphanumeric strings corresponding to the device on which the app was used. The appeals court in six-sentence order, opens new tab on June 17 denied Flo's petition and declined to stay the lower court proceedings. 'Cases of this magnitude almost never proceed to trial,' Flo noted in its appeal, describing the 'hydraulic pressure' to settle. I can only imagine. But if it does indeed go to trial, all I can say is, pass the popcorn.
Reuters
26 minutes ago
- Reuters
Law firm Milbank defends NJ cities in Trump immigration lawsuit
July 15 (Reuters) - U.S. law firm Milbank has signed on to defend two New Jersey cities that were sued by President Donald Trump's administration over their immigration policies, putting the firm at odds with the White House after it struck a deal in April to avert the president's crackdown on prominent firms. A team of Milbank lawyers is representing Newark and Hoboken in the case in federal court, new court papers showed this week. They include former Obama-era acting U.S. Solicitor General Neal Katyal and Gurbir Grewal, a former New Jersey attorney general and enforcement head at the U.S. Securities and Exchange Commission. The Trump administration in May sued Newark, Hoboken and other New Jersey cities, accusing them of being so-called sanctuary jurisdictions and obstructing federal immigration agents. The lawsuit, filed in Newark, was part of the White House's broader hardline campaign against immigration. Milbank, Katyal, Grewal and the White House did not immediately respond to requests for comment. New York-headquartered Milbank is one of nine firms that reached deals with Trump in March and April, after he began issuing executive orders against law firms that restricted their access to government officials and federal contracting work. Four other law firms successfully sued to block Trump's orders against them. Trump in his orders alleged major firms had "weaponized" the legal system through politicized cases and hires, and accused them of illegal employment practices focused on racial diversity. To rescind or head off such orders, the settling firms pledged nearly $1 billion in free legal services to mutually agreed-upon initiatives with the White House, among other concessions. Milbank, which had not been hit with an executive order, said it earmarked $100 million. Milbank Chairman Scott Edelman in a letter to the firm in April said the administration had approached it with concerns about its pro bono and diversity initiatives, suggesting it make a deal. The New Jersey case is one of at least three in which Milbank now represents Trump's legal opponents. Katyal represents a former federal official suing over what she said was her wrongful termination from a board overseeing employment complaints by government workers. He is also representing a group of five small businesses that sued to challenge Trump's across-the-board taxes on imports from nations that sell more to the United States than they buy. The administration has appealed a ruling the plaintiffs won in May. Milbank hired Grewal last year from the SEC, where he had led enforcement efforts since 2021. Katyal joined the firm in February from rival law firm Hogan Lovells, and now leads Milbank's appellate team. He has argued more than 50 cases before the U.S. Supreme Court. The case is United States v. City of Newark et al, U.S. District Court for the District of New Jersey, No. 2:25-cv-05081-EP-AME. Read more: Small businesses sign up prominent appellate attorney Neal Katyal in tariff case From Harvard to Musk, law firm Quinn Emanuel juggles Trump's friends and foes Law firms hire former Tesla lawyer and top conservative litigator for Trump fight Obama's top Supreme Court lawyer files lawsuit over Trump funding freeze
